American Society of Hirudotherapy

Evolving Antibiotic Resistance of Aeromonas Species in Finger Replantation

Case series published in Surgical Infections (2019)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Research reportSafety & Infection ControlMokhtar K, Culnan DM, Lineaweaver WC · Surgical infections, 2020

Abstract

Background: Infections with Aeromonas spp. are a recognized complication of leech therapy for circulatory complications in replanted digits. Ciprofloxacin is commonly used empirically for Aeromonas coverage in such cases. Evolving resistance patterns of Aeromonas should be considered in designing an antibiotic strategy. Methods: Three consecutive patients with complicated replantations had site cultures yielding Aeromonas isolates resistant to ciprofloxacin. These cultures were analyzed to identify effective antibiotic agents. Results: Each Aeromonas isolate, and each additional site organism, was sensitive to cefepime. Conclusion: Our routine antibiotic coverage for leech application has been changed to cefepime. Aeromonas sensitivities and resistances should be monitored to adapt to future changes in appropriate antibiotics.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAeromonasAnti-Bacterial AgentsCefepimeCiprofloxacinDrug Resistance, MicrobialHumansLeechingMicrobial Sensitivity TestsReplantation

Summary

Three consecutive patients with complicated finger replantations treated with leech therapy developed ciprofloxacin-resistant Aeromonas isolates sensitive to cefepime, prompting a switch in empirical antibiotic coverage.

Why This Matters for Hirudotherapy

This report examined Aeromonas infection complicating leech therapy after digit replantation, describing three consecutive patients whose site cultures yielded ciprofloxacin-resistant Aeromonas isolates and testing those isolates for effective antibiotics. For hirudotherapy, it is directly relevant because Aeromonas infection is a recognized complication of medicinal leech use in replanted digits; emerging ciprofloxacin resistance challenges commonly used empirical coverage, and the finding that each isolate was sensitive to cefepime led the authors to change their routine leech-application antibiotic to cefepime. The key caveat is that this is a small case series, not a comparative trial or resistance-surveillance study, so it cannot define general prevalence or universal prophylaxis; local sensitivities should be monitored and treatment individualized.

Citation

Reference (Vancouver style)

Mokhtar K, Culnan DM, Lineaweaver WC. Evolving Antibiotic Resistance of Aeromonas Species in Finger Replantation. Surg Infect (Larchmt). 2020;21(2):158-160. doi:10.1089/sur.2019.067. PMID: 31556841

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 26, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.